Details
| Stereochemistry | MIXED |
| Molecular Formula | C21H25NO2.BrH |
| Molecular Weight | 404.341 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.CC1N(CC(=O)C2=CC=CC=C2)CCCC1(C)C3=CC=CC(O)=C3
InChI
InChIKey=QPYBKRQAZDDXJD-UHFFFAOYSA-N
InChI=1S/C21H25NO2.BrH/c1-16-21(2,18-10-6-11-19(23)14-18)12-7-13-22(16)15-20(24)17-8-4-3-5-9-17;/h3-6,8-11,14,16,23H,7,12-13,15H2,1-2H3;1H
Myfadol is a phenacylpiperidine derivative patented by Tanabe Seiyaku Co., Ltd as low molecular weight non-peptide analgesic. Myfadol produces hot-plate analgesia in rodents with minimal side-effects, and when given parenterally in humans produces analgesia to experimentally-produced and postoperative pain.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8LPI7L05MJ
Created by
admin on Sat Dec 16 18:32:30 GMT 2023 , Edited by admin on Sat Dec 16 18:32:30 GMT 2023
|
PRIMARY | |||
|
469-17-0
Created by
admin on Sat Dec 16 18:32:30 GMT 2023 , Edited by admin on Sat Dec 16 18:32:30 GMT 2023
|
PRIMARY | |||
|
72941435
Created by
admin on Sat Dec 16 18:32:30 GMT 2023 , Edited by admin on Sat Dec 16 18:32:30 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
